EU
ALNY icon

Emory University’s Alnylam Pharmaceuticals ALNY Stock Holding History

Emory University’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,959
Closed -$2.33M – 46
2018
Q4 		$2.33M Buy
31,959
+4,275
+15% +$329K 1.84% 12
2018
Q3 		$2.42M Buy
27,684
+1,428
+5% +$144K 1.59% 27
2018
Q2 		$2.59M Buy
26,256
+4,940
+23% +$490K 1.72% 19
2018
Q1 		$2.54M Buy
21,316
+6,972
+49% +$899K 1.81% 17
2017
Q4 		$1.82M Sell
14,344
-6,316
-31% -$794K 1.56% 30
2017
Q3 		$2.43M Sell
20,660
-922
-4% -$78.7K 1.92% 5
2017
Q2 		$1.72M Buy
+21,582
New +$1.38M 1.52% 11

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return